Search Results 331-340 of 15915 for SC
... SC, Yau E, Gregory KM, Hughes M. NCCN Guidelines(R) Insights: Non-Small Cell Lung Cancer, Version 2.2023. J Natl Compr Canc Netw. 2023 Apr; 21 (4):340-350
Source: Cho, J. Seville, MT. Khanna, S. Pardi, DS. Sampathkumar, P. Kashyap, PC. Screening for. Clostridium difficile colonization on admission to a ...
The purpose of this study is to evaluate effects on proteinuria and glomerular filtration rate of sibeprenlimab 400 mg subcutaneously (s.c.) Q 4 weeks in ...
The purpose of this study is to evaluate the safety and effectiveness of repeated subcutaneous (SC) administrations of Lanadelumab in preventing angioedema ...
This is a multicenter, open-label, Phase 1 study in participants with colorectal cancer (CRC) or gastric cancer to study the safety and tolerability of SC ...
Jonathan Vandenberg, M.D.. Medical school: University of South Carolina. PGY-5. Class of 2027. Monica Mazur, M.D.. Monica Price, M.D.. Medical school: Rush ...
... (sc) to adult subjects with suspected or confirmed diagnosis of noncirrhotic nonalcoholic steatohepatitis (NASH) with no fibrosis to moderate fibrosis ...
He completed advanced endoscopic training at the Medical University of South Carolina under the mentor ship of Dr. ... South Carolina. 2001. MemberSearch ...
Michael Farkouh, M.D., M.Sc., cardiologist, Peter Munk Cardiac Centre, University Health Network, and principal investigator, describes this large, simple ...
... SC, Sridharan M. Complement gene variant effect on relapse of complement-mediated thrombotic microangiopathy after eculizumab cessation. Blood Adv. 2023 Feb ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.